Equities

Revenio Group Oyj

Revenio Group Oyj

Actions
Health CareMedical Equipment and Services
  • Price (EUR)28.66
  • Today's Change-0.540 / -1.85%
  • Shares traded6.20k
  • 1 Year change+25.37%
  • Beta1.3963
Data delayed at least 15 minutes, as of Nov 13 2024 14:40 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

  • Revenue in EUR (TTM)102.08m
  • Net income in EUR19.01m
  • Incorporated2001
  • Employees230.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Stille AB42.10m4.39m166.09m151.0033.822.8625.633.946.336.3360.9474.850.69782.108.494,598,368.007.287.038.708.1949.1743.9310.439.851.127.410.0021.9819.7016.78-2.485.3423.62--
Detection Technology Oyj-100.00bn-100.00bn205.18m464.00--2.78----------5.03----------9.34--11.96--47.44--8.223.39--0.0053.455.292.027.55-18.03-14.88-9.55
BICO Group AB194.55m-67.96m217.89m828.00--0.874--1.12-11.15-15.2031.9241.790.36022.154.472,547,964.00-12.62---14.44--55.70---35.03--2.23-0.57050.397--6.09---1,889.33------
Medistim ASA46.52m8.64m219.06m152.0025.326.3520.344.715.555.5529.8722.121.130.74617.483,599,204.0021.0522.9325.5328.5279.1278.2518.5820.642.75--0.018175.257.0010.06-8.9112.720.03314.87
RaySearch Laboratories AB (publ)100.97m15.12m453.56m414.0038.648.3412.614.495.105.1034.0923.650.60235.513.293,005,152.009.021.2913.691.8891.0690.5714.972.551.27108.610.370669.0021.1610.26243.060.7648-1.31--
CellaVision AB63.67m12.97m499.60m228.0038.517.5330.157.856.306.3030.9132.190.78491.917.263,233,162.0015.9915.3018.4518.2466.9969.0320.3819.982.151,358.860.044110.185.9413.1710.128.0030.458.45
Surgical Science Sweden AB72.40m17.08m515.67m265.0030.201.3023.387.123.873.8716.4390.020.16951.497.353,224,027.004.004.494.264.7868.5170.0623.5923.753.46--0.000.0010.0168.1424.47--38.57--
Arjo AB (publ)965.86m44.14m770.98m6.85k18.721.225.960.79821.881.8841.0528.870.71494.546.781,644,896.003.263.554.625.5543.6444.014.565.410.6263.970.407343.0110.035.976.9010.15-8.8910.35
Revenio Group Oyj102.08m19.01m779.09m230.0040.537.6732.127.630.72040.72043.863.810.78344.938.17472,574.1014.6714.3317.0917.9049.2950.7318.7221.131.5134.570.127655.81-0.412525.80-12.1518.7217.676.30
ChemoMetec A/S54.68m18.27m1.10bn173.0060.4014.5653.4520.187.837.8323.4432.480.61120.7456.972,357,630.0020.4227.9624.4035.1078.8079.5733.4135.023.76--0.0073144.08-8.2218.37-23.7226.649.97-11.81
Biotage AB183.72m22.20m1.12bn675.0050.293.3929.506.073.213.2126.5647.600.43121.597.223,155,786.005.2110.746.0512.7762.6761.4012.0815.751.1543.880.061640.1119.5415.50-8.217.9714.051.30
Data as of Nov 13 2024. Currency figures normalised to Revenio Group Oyj's reporting currency: Euro EUR

Institutional shareholders

23.04%Per cent of shares held by top holders
HolderShares% Held
Threadneedle Asset Management Ltd.as of 24 Apr 20231.18m4.43%
The Vanguard Group, Inc.as of 02 Oct 2024857.80k3.22%
Swedbank Robur Fonder ABas of 30 Sep 2024759.00k2.85%
Keskin�inen El�kevakuutusyhti� Ilmarinenas of 31 Dec 2023699.79k2.62%
SEB Wealth Management Finland Ltd.as of 30 Sep 2024611.04k2.29%
Norges Bank Investment Managementas of 24 Apr 2023555.45k2.08%
Keskin�inen Ty�el�kevakuutusyhti� Eloas of 31 Dec 2023386.00k1.45%
Handelsbanken Fonder ABas of 31 Oct 2024385.59k1.45%
Teknik Innovation Norden Fonder ABas of 31 Dec 2022367.87k1.38%
Groupama Asset Management SAas of 24 Apr 2023341.43k1.28%
More ▼
Data from 31 Dec 2022 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.